BLUE BIRD CORP (BLBD) Fundamental Analysis & Valuation

NASDAQ:BLBD • US0953061068

Current stock price

53.38 USD
-0.12 (-0.22%)
At close:
53.38 USD
0 (0%)
After Hours:

This BLBD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. BLBD Profitability Analysis

1.1 Basic Checks

  • BLBD had positive earnings in the past year.
  • BLBD had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: BLBD reported negative net income in multiple years.
  • In multiple years BLBD reported negative operating cash flow during the last 5 years.
BLBD Yearly Net Income VS EBIT VS OCF VS FCFBLBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • The Return On Assets of BLBD (20.20%) is better than 98.47% of its industry peers.
  • BLBD's Return On Equity of 47.81% is amongst the best of the industry. BLBD outperforms 97.71% of its industry peers.
  • BLBD has a better Return On Invested Capital (31.20%) than 99.24% of its industry peers.
  • BLBD had an Average Return On Invested Capital over the past 3 years of 29.27%. This is significantly above the industry average of 10.16%.
  • The 3 year average ROIC (29.27%) for BLBD is below the current ROIC(31.20%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROIC 31.2%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
BLBD Yearly ROA, ROE, ROICBLBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

1.3 Margins

  • BLBD has a better Profit Margin (8.65%) than 69.47% of its industry peers.
  • In the last couple of years the Profit Margin of BLBD has grown nicely.
  • Looking at the Operating Margin, with a value of 11.46%, BLBD is in line with its industry, outperforming 59.54% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BLBD has grown nicely.
  • BLBD has a worse Gross Margin (20.97%) than 68.70% of its industry peers.
  • In the last couple of years the Gross Margin of BLBD has grown nicely.
Industry RankSector Rank
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
BLBD Yearly Profit, Operating, Gross MarginsBLBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BLBD Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BLBD is creating value.
  • The number of shares outstanding for BLBD has been reduced compared to 1 year ago.
  • The number of shares outstanding for BLBD has been increased compared to 5 years ago.
  • Compared to 1 year ago, BLBD has an improved debt to assets ratio.
BLBD Yearly Shares OutstandingBLBD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
BLBD Yearly Total Debt VS Total AssetsBLBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • BLBD has an Altman-Z score of 6.53. This indicates that BLBD is financially healthy and has little risk of bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.53, BLBD belongs to the top of the industry, outperforming 85.50% of the companies in the same industry.
  • The Debt to FCF ratio of BLBD is 0.55, which is an excellent value as it means it would take BLBD, only 0.55 years of fcf income to pay off all of its debts.
  • BLBD has a better Debt to FCF ratio (0.55) than 91.60% of its industry peers.
  • A Debt/Equity ratio of 0.31 indicates that BLBD is not too dependend on debt financing.
  • BLBD has a Debt to Equity ratio of 0.31. This is in the better half of the industry: BLBD outperforms 64.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Altman-Z 6.53
ROIC/WACC3.3
WACC9.46%
BLBD Yearly LT Debt VS Equity VS FCFBLBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that BLBD should not have too much problems paying its short term obligations.
  • With a Current ratio value of 1.81, BLBD is not doing good in the industry: 61.07% of the companies in the same industry are doing better.
  • BLBD has a Quick Ratio of 1.21. This is a normal value and indicates that BLBD is financially healthy and should not expect problems in meeting its short term obligations.
  • BLBD has a Quick ratio (1.21) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.21
BLBD Yearly Current Assets VS Current LiabilitesBLBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BLBD Growth Analysis

3.1 Past

  • BLBD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.08%, which is quite impressive.
  • BLBD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 39.87% yearly.
  • BLBD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.61%.
  • BLBD shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.98% yearly.
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%

3.2 Future

  • Based on estimates for the next years, BLBD will show a small growth in Earnings Per Share. The EPS will grow by 6.23% on average per year.
  • BLBD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.93% yearly.
EPS Next Y5.61%
EPS Next 2Y7.87%
EPS Next 3Y6.23%
EPS Next 5YN/A
Revenue Next Year6.01%
Revenue Next 2Y6.19%
Revenue Next 3Y4.48%
Revenue Next 5Y5.93%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BLBD Yearly Revenue VS EstimatesBLBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
BLBD Yearly EPS VS EstimatesBLBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

7

4. BLBD Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 11.94, the valuation of BLBD can be described as reasonable.
  • Based on the Price/Earnings ratio, BLBD is valued cheaply inside the industry as 92.37% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of BLBD to the average of the S&P500 Index (25.71), we can say BLBD is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.45, the valuation of BLBD can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, BLBD is valued cheaply inside the industry as 94.66% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of BLBD to the average of the S&P500 Index (23.83), we can say BLBD is valued rather cheaply.
Industry RankSector Rank
PE 11.94
Fwd PE 10.45
BLBD Price Earnings VS Forward Price EarningsBLBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 90.84% of the companies in the same industry are more expensive than BLBD, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, BLBD is valued cheaper than 93.13% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.37
EV/EBITDA 8.18
BLBD Per share dataBLBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLBD does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of BLBD may justify a higher PE ratio.
PEG (NY)2.13
PEG (5Y)0.3
EPS Next 2Y7.87%
EPS Next 3Y6.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLBD Dividend Analysis

5.1 Amount

  • BLBD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLBD Fundamentals: All Metrics, Ratios and Statistics

BLUE BIRD CORP

NASDAQ:BLBD (3/13/2026, 8:11:51 PM)

After market: 53.38 0 (0%)

53.38

-0.12 (-0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-04
Earnings (Next)05-05
Inst Owners116.4%
Inst Owner Change1.79%
Ins Owners0.51%
Ins Owner Change3.45%
Market Cap1.69B
Revenue(TTM)1.50B
Net Income(TTM)129.75M
Analysts82.86
Price Target67.83 (27.07%)
Short Float %14.11%
Short Ratio9.33
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.62%
Min EPS beat(2)20.09%
Max EPS beat(2)25.16%
EPS beat(4)3
Avg EPS beat(4)16.38%
Min EPS beat(4)-0.8%
Max EPS beat(4)25.16%
EPS beat(8)7
Avg EPS beat(8)30.67%
EPS beat(12)11
Avg EPS beat(12)59.19%
EPS beat(16)12
Avg EPS beat(16)-79.92%
Revenue beat(2)2
Avg Revenue beat(2)2.88%
Min Revenue beat(2)0.25%
Max Revenue beat(2)5.51%
Revenue beat(4)3
Avg Revenue beat(4)2.03%
Min Revenue beat(4)-0.95%
Max Revenue beat(4)5.51%
Revenue beat(8)5
Avg Revenue beat(8)3.11%
Revenue beat(12)9
Avg Revenue beat(12)4.96%
Revenue beat(16)12
Avg Revenue beat(16)7.06%
PT rev (1m)4.31%
PT rev (3m)4.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.57%
EPS NY rev (1m)5.12%
EPS NY rev (3m)5.02%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-7.28%
Revenue NY rev (1m)1.16%
Revenue NY rev (3m)1.16%
Valuation
Industry RankSector Rank
PE 11.94
Fwd PE 10.45
P/S 1.12
P/FCF 10.37
P/OCF 9.05
P/B 6.21
P/tB 7.98
EV/EBITDA 8.18
EPS(TTM)4.47
EY8.37%
EPS(NY)5.11
Fwd EY9.57%
FCF(TTM)5.15
FCFY9.64%
OCF(TTM)5.9
OCFY11.05%
SpS47.46
BVpS8.59
TBVpS6.69
PEG (NY)2.13
PEG (5Y)0.3
Graham Number29.39
Profitability
Industry RankSector Rank
ROA 20.2%
ROE 47.81%
ROCE 42.19%
ROIC 31.2%
ROICexc 76.78%
ROICexgc 120.5%
OM 11.46%
PM (TTM) 8.65%
GM 20.97%
FCFM 10.85%
ROA(3y)15.41%
ROA(5y)6.73%
ROE(3y)58.56%
ROE(5y)N/A
ROIC(3y)29.27%
ROIC(5y)N/A
ROICexc(3y)58.87%
ROICexc(5y)N/A
ROICexgc(3y)104.89%
ROICexgc(5y)N/A
ROCE(3y)39.57%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y47.59%
ROICexc growth 3YN/A
ROICexc growth 5Y50.42%
OM growth 3YN/A
OM growth 5Y35.18%
PM growth 3YN/A
PM growth 5Y44.13%
GM growth 3Y65.07%
GM growth 5Y13.39%
F-Score7
Asset Turnover2.33
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF 0.55
Debt/EBITDA 0.45
Cap/Depr 151.15%
Cap/Sales 1.58%
Interest Coverage 26.47
Cash Conversion 99.4%
Profit Quality 125.35%
Current Ratio 1.81
Quick Ratio 1.21
Altman-Z 6.53
F-Score7
WACC9.46%
ROIC/WACC3.3
Cap/Depr(3y)101.02%
Cap/Depr(5y)87.95%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.2%
Profit Quality(3y)226.25%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.08%
EPS 3YN/A
EPS 5Y39.87%
EPS Q2Q%8.7%
EPS Next Y5.61%
EPS Next 2Y7.87%
EPS Next 3Y6.23%
EPS Next 5YN/A
Revenue 1Y (TTM)11.61%
Revenue growth 3Y22.73%
Revenue growth 5Y10.98%
Sales Q2Q%6.12%
Revenue Next Year6.01%
Revenue Next 2Y6.19%
Revenue Next 3Y4.48%
Revenue Next 5Y5.93%
EBIT growth 1Y27.81%
EBIT growth 3YN/A
EBIT growth 5Y50.02%
EBIT Next Year34.98%
EBIT Next 3Y13.5%
EBIT Next 5YN/A
FCF growth 1Y80.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.98%
OCF growth 3YN/A
OCF growth 5Y119.48%

BLUE BIRD CORP / BLBD Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BLUE BIRD CORP?

ChartMill assigns a fundamental rating of 6 / 10 to BLBD.


What is the valuation status for BLBD stock?

ChartMill assigns a valuation rating of 7 / 10 to BLUE BIRD CORP (BLBD). This can be considered as Undervalued.


Can you provide the profitability details for BLUE BIRD CORP?

BLUE BIRD CORP (BLBD) has a profitability rating of 7 / 10.


What are the PE and PB ratios of BLUE BIRD CORP (BLBD) stock?

The Price/Earnings (PE) ratio for BLUE BIRD CORP (BLBD) is 11.94 and the Price/Book (PB) ratio is 6.21.


Can you provide the expected EPS growth for BLBD stock?

The Earnings per Share (EPS) of BLUE BIRD CORP (BLBD) is expected to grow by 5.61% in the next year.